Showing results (2531-2540 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|April 27, 2018
Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)M E M van der Noordaa, F H van Duijnhoven, C E Loo, et al.Breast (Edinburgh, Scotland)|May 16, 2017
Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective studyJulien Viot, Martin Bachour, Aurélia Meurisse, et al.Breast (Edinburgh, Scotland)|July 21, 2018
Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012Paramita Dasgupta, Joanne F Aitken, Christopher Pyke, et al.Breast (Edinburgh, Scotland)|November 18, 2005
HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred casesA Sáez, F J Andreu, M A Seguí, et al.Breast (Edinburgh, Scotland)|October 20, 2009
Neoadjuvant endocrine treatment in primary breast cancer - review of literatureJ Mathew, K S Asgeirsson, L R Jackson, et al.Breast (Edinburgh, Scotland)|December 21, 2005
Management of chylous leakage after axillary lymph node dissection in a patient undergoing breast surgeryMasashi Haraguchi, Tamotsu Kuroki, Noritsugu Tsuneoka, et al.Breast (Edinburgh, Scotland)|November 9, 2005
Adjuvant endocrine therapies for pre-/perimenopausal womenKathleen I PritchardBreast (Edinburgh, Scotland)|September 7, 2018
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?Anna Tessari, Lorenzo Pilla, Damian Silvia, et al.Breast (Edinburgh, Scotland)|August 13, 2018
Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studiesSilvia M Ess, Christian Herrmann, Christine Bouchardy, et al.Breast (Edinburgh, Scotland)|August 13, 2018
A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with single stage implant reconstruction in the treatment of breast cancerAmmar Asban, Christopher Homsy, Lilian Chen, et al.Pageof 367